Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

A groundbreaking study reveals that a single dose of psilocybin, the active compound in magic mushrooms, can provide ...

New research shows a single psilocybin session with therapy can reduce depression in cancer patients for up to two years.

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

Scientists have dug up more evidence of the benefits of so-called "magic" mushrooms with the publication of clinical trial results showing how a compound at the root of their nickname leads to ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

New Zealand approves use of ‘magic mushrooms’ to treat depression but only one psychiatrist is allowed to prescribe it - New ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.